Tivicay 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ89Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,719
Award facts
- Contract value 100% obligated
- $15,718.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,718.76 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count packages) on December 5, 2025, with completion expected by December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tivicay (dolutegravir) is an antiretroviral medication used in HIV treatment regimens, reflecting the DLA's ongoing pharmaceutical procurement needs to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, medical supplies, and specialty pharmaceuticals serving the Defense Health Agency and other government healthcare entities. The company's demonstrated capability to fulfill competitive federal procurement requirements across a broad spectrum of therapeutic domains has established it as a primary provider within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FZ89Q?
SPE2DR26FZ89Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FZ89Q worth?
The government has obligated $15,719 on SPE2DR26FZ89Q.
Is contract SPE2DR26FZ89Q an order under another contract?
Yes. SPE2DR26FZ89Q is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ89Q competed?
The extent of competition for SPE2DR26FZ89Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award